Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
about
Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniaePatterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United StatesA functional classification scheme for beta-lactamases and its correlation with molecular structureComparison of five different methods for detection of SHV extended-spectrum beta-lactamases.Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from AlgeriaOutbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gMolecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistanceCoexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospitalDevelopment of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family EnterobacteriaceaeNosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.Beta-lactamase nomenclature.Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamaseOutbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityMulticenter in vitro evaluation of SM-7338, a new carbapenem.Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids.TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coliStructural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamaseFrequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216.Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional testsRelationship between adhesion to intestinal Caco-2 cells and multidrug resistance in Klebsiella pneumoniae clinical isolatesTranslocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli.R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections.Quantifying nonspecific TEM beta-lactamase (blaTEM) genes in a wastewater streamProspective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit.More extended-spectrum beta-lactamasesMolecular evolution of ubiquitous beta-lactamases towards extended-spectrum enzymes active against newer beta-lactam antibiotics.Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam.Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.Characterization of the Novel CMT Enzyme TEM-154Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases.
P2860
Q24674937-D1784065-810A-4A25-BEAA-BE9CC68DC19FQ24676380-BD64C749-D08F-4563-BBD7-EB526FD921E7Q24677460-FE015FE0-BBB0-4950-B183-70E70AF29086Q32100538-8F698319-7BD3-4A0D-9DE8-38CDE7761F29Q33558869-B1229A02-13B4-40AD-B9D8-7AAF300572C6Q33702657-E678658D-5B30-4D0A-A477-A9011725F87EQ33747222-DCB09B7E-16DE-4A35-904E-12F8BCD38065Q33972569-569ECACB-A048-46A0-9B68-EF7B184AD3CEQ34132715-A434062C-FF2B-4F96-BB46-501C9AF4340FQ34139810-41F505AF-0EDF-4802-A90E-790A8F4C2D01Q34510623-D7ACA6FA-5EF6-4C3C-8721-85AD4F88374DQ35264577-3A0F6821-9EEE-40C0-9B9D-BDB12C1EB8E5Q35281765-FEA5A6B0-8735-43A7-B8B9-4CDC88AFA259Q35328263-282E399E-5DCA-43F9-AC6F-DF214A4A8393Q35333991-A5939596-79C3-4E8F-A4FE-065B3A8737AAQ35347506-D4B317EE-B321-4E4F-AAAB-22818EDB2F0AQ35359453-93185E7D-EF1B-4506-B908-425509B1F8D4Q35360336-1050BBB1-B914-4043-AF3E-B062DFFF09F8Q35364989-FD2A25B1-5E38-4992-9864-203FB56623F6Q35564179-F9CE7635-FDD5-470C-A172-F64A226C9786Q35564595-7C9971A7-7A3E-4D2A-80A8-15C9DFB8B047Q35618125-826079BF-8E65-4248-8B8B-93B3B61A68BAQ35847267-936B85A6-3D75-4AF6-A7E0-A940FBBABB94Q35896953-8456E633-BF00-4768-B2A5-4A639587BDA8Q36544571-E7FDB445-D1F7-43D1-A210-B711A793061BQ36754490-0FA0CF64-ACA1-4164-8EE2-D434CED8927FQ36953629-8EDCE1FF-62D6-4232-ABF7-971682694071Q37032925-4611C9F2-4198-41BB-90F3-350062DFE16CQ37165053-5125939F-4C76-4FA5-97BF-50E0E33B0319Q37520309-3949C8C6-0C62-4887-9252-EA34F940A8C4Q37782936-9EA45C9E-F7BD-4902-A76A-7D9E916F9396Q38640013-3339DF2B-1DEC-4CC2-8E6D-06C58E86C93EQ39814786-B46C081D-7A00-49CC-9BE1-F0F1D5C4BDD4Q39865919-D425FAD5-0D80-4BD9-9BB8-365723366BB9Q40087113-79A16952-13AA-4D72-AD59-55C3E7FAB610Q40284079-FD3EB724-35B1-4065-9E0F-357EBDDF88EAQ40285545-ABFB0292-9FF8-47F1-8810-F4256AFE64D8Q41483377-6FFF7593-E37D-4C6F-AD67-10DE13E3E715Q42276254-8109D21F-3DA3-4B0F-90E8-1D60A3122E36Q43503024-0D12EA2A-B5DD-469C-A520-B444C9EF9CC1
P2860
Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@ast
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@en
type
label
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@ast
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@en
prefLabel
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@ast
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@en
P2093
P2860
P356
P1476
Novel plasmid-mediated beta-la ...... broad-spectrum cephalosporins.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.5.626
P407
P577
1988-05-01T00:00:00Z